Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: Contraception

  • Study confirms impact of OCs on dysmenorrhea

    Results from a large, long-running Scandinavian study provides convincing evidence that combined oral contraceptives (OCs) alleviate the symptoms of dysmenorrhea, painful menstrual periods.
  • HPV shot doesn't trigger autoimmune response

    New research indicates that the human papillomavirus vaccine (HPV) Gardasil (Merck & Co.) does not trigger autoimmune conditions such as lupus, rheumatoid arthritis, type 1 diabetes, or multiple sclerosis after vaccination in young women.
  • Pfizer issues recalls for Akrimax OCs

    Has your clinic telephone been ringing recently with calls from women who have heard about a birth control pill recall? Chances are, few, if any, of your patients were using the affected oral contraceptives (OCs).
  • The 'Get It and Forget It' methods are here: Remove obstacles to use

    Where do long-acting reversible contraceptives (LARC) fit in at your facility? How are you encouraging women to use the "Get It and Forget It" methods? If you are seeing low numbers of women choosing intrauterine devices (IUDs) or the contraceptive implant, you might want to change your counseling strategy.
  • Circumcision devices eyed in HIV prevention

    Now that male circumcision has been associated with a lower risk for HIV infection in international observational studies and in three randomized controlled clinical trials, international health officials are looking at options in making it more available to men at risk.
  • OTC access to EC blocked — What's next?

    Almost 75% of respondents to the Contraceptive Technology Update 2011 Contraception Survey say they provide advance provision of emergency contraception (EC).
  • Set to change: Patch, drospirenone OC labels

    New labeling is being eyed regarding increased risks for blood clots for the contraceptive patch and combined oral contraceptives (COCs) containing the progestin drospirenone (DRSP) following recommendations from joint votes from two Food and Drug Administration (FDA) committees.
  • Readers speak out on status of the Pill

    While combined oral contraceptives (OCs) remain a leading choice for contraception, other methods are making their mark. About 38% of respondents to the 2011 Contraceptive Technology Update Contraception Survey said more than half of their patients use OCs, a drop from 2010's 42% level.
  • How do you use OCs? Clinicians share tips

    A woman comes into your office and says she wants to use an oral contraceptive (OC) for birth control. After confirming that she is a good candidate for the method, when do you start her on her first pack of pills?
  • New develoment: More women report making the move to LARC

    While pills remain a popular birth control choice, more women are selecting long-acting reversible contraception (LARC), say respondents to the 2011 Contraceptive Technology Update Contraception Survey. More than 80% of respondents say they have seen an increase in LARC methods.